The blushwood berry, derived from the Australian blushwood tree (Hylandia dockrillii), has garnered significant attention in recent years due to its remarkable potential in cancer treatment. This unique fruit is the source of EBC-46, an experimental drug that has demonstrated the ability to destroy tumors in various animal models, achieving long-term remission in over 70% of cases. Research indicates that the compound works by inducing a rapid immune response and cutting off the tumor's blood supply, leading to swift tumor regression. Additionally, the berry is rich in bioactive compounds that may contribute to its antioxidant properties and potential metabolic benefits. This resource page aims to compile a collection of articles and scientific studies that explore the therapeutic applications, biochemical properties, and ongoing research surrounding the blushwood berry, highlighting its promise as a novel approach to cancer prevention and treatment in pets and humans.

While much of the research centers on creating a synthetic version of the compound EBC-46 for patent, distribution, and financial gain, we will continue to offer blushwood berry in its most natural and pure form.

QBiotics wins FDA orphan status for rainforest-derived cancer drug
This article stipulates that even though the designation is for soft tissue sarcoma, tigilanol tiglate is in clinical trials for multiple cancer types.
Read more here.

From the Bush to the Brain: Preclinical Stages of Ethnobotanical Anti-Inflammatory and Neuroprotective Drug Discovery—An Australian Example
This article discusses EBC-46, a compound derived from the seeds of the blushwood tree (Hylandia dockrillii), and its potential applications in drug discovery and cancer treatment.
Read more here.

Breakthrough in Production of Cancer-Treating Drug
This report details the synthetic production of EBC-46 and its mechanism of action in treating tumors, highlighting its effectiveness in animal models and its potential for human clinical trials.
Read more here.

Cancer Tumors Destroyed by Berry Found in Queensland Rainforest
This study outlines the effectiveness of EBC-46 in destroying cancerous tumors in animal models, providing insights into its rapid action and potential as a treatment option.
Read more here.

Rare Australian Berries Might Contain Possible Cancer Treatment
This article discusses the discovery of EBC-46 and its promising results in preclinical trials for treating various types of cancer in animals, emphasizing its unique properties derived from the blushwood berry.
Read more here.

Scientists Discover Cancer-Fighting Berry on Tree that Only Grows in Far North Queensland
This piece reports on the rapid tumor-fighting properties of EBC-46 and its successful application in veterinary medicine, with a focus on ongoing research for human applications.
Read more here.